Drug Trial Radar · NCT07940582
A Research Study Investigating How a New Medicine NNC0721-5186 Works in Women Living With Overweight or Obesity
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
102
Planned (sponsor's estimate)
Start
Nov 13, 2026
Primary completion
May 29, 2028
Study completion May 29, 2028
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Nov 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to look at the safety and how the body takes up, breaks down and removes NNC0721-5186 in people living with overweight or obesity when compared to placebo. In the first 3 dosing groups, NNC0721-5186 will also be compared with semaglutide, a medicine already approved for weight management. Participants will either get NNC0721-5186, semaglutide, or placebo. Which treatment participants get is decided by chance.
Conditions
- Overweight
- Obesity
Interventions
NNC0721-5186Drug
NNC0721-5186 is administered as a single subcutaneous injection.
SemaglutideDrug
Semaglutide is administered as a single subcutaneous injection using a pen-injector.
Placebo (NNC0721-5186)Drug
Placebo is administered as a single subcutaneous injection matching NNC0721-5186.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of treatment-emergent adverse events (TEAEs)Time frame: From time of dosing (Day 1) to Day 36
Locations
1 site in 1 country. Site status is shown where the registry gives one.
[Legal] Altasciences Clinical Los Angeles, Inc. & Altasciences Professional Los Angeles, P.C.
Cypress, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.